郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Development of Leishmania donovani stably expressing DsRed for flow cytometry-based drug screening using chalcone thiazolyl-hydrazone as a new antileishmanial target.

期刊:International journal of antimicrobial agents发表年份:2016作者:Anil Kumar Jaiswal; K Bhaskara Rao; Pragati Kushwaha; Keerti Rawat; Ram K Modukuri; Prashant Khare; Sumit Joshi; Shikha Mishra; Ambak Rai; Koneni V Sashidhara; Anuradha Dube

药效评价High avidity chimeric monoclonal antibodies against the extracellular domains of human aquaporin-4 competing with the neuromyelitis optica autoantibody, NMO-IgG.

期刊:British journal of pharmacology发表年份:2016作者:Kaori Miyazaki-Komine; Yoshiki Takai; Ping Huang; Osamu Kusano-Arai; Hiroko Iwanari; Tatsuro Misu; Katsushi Koda; Katsuyuki Mitomo; Toshiko Sakihama; Yoshiaki Toyama; Kazuo Fujihara; Takao Hamakubo; Masato Yasui; Yoichiro Abe

药效评价Characterization of PCS1055, a novel muscarinic M4 receptor antagonist.

期刊:European journal of pharmacology发表年份:2016作者:Carrie H Croy; Wai Y Chan; Andrea M Castetter; Marla L Watt; Anne T Quets; Christian C Felder

药效评价4-amino-6-alkyloxy-2-alkylthiopyrimidine derivatives as novel non-nucleoside agonists for the adenosine A1 receptor.

期刊:Chemical biology & drug design发表年份:2016作者:Barbara Cosimelli; Giovanni Greco; Sonia Laneri; Ettore Novellino; Antonia Sacchi; Maria Letizia Trincavelli; Chiara Giacomelli; Sabrina Taliani; Federico Da Settimo; Claudia Martini